SEC Filings

Document Details

Form
Filing Date
09/12/18
Document Date
09/10/18
Form Description
Initial filing by director officer or owner of more than ten percent.
Filing Group
3,4,5
Company
Cidara Therapeutics, Inc.
Issuer
K2 THERAPEUTICS, INC.
Filer
Gollaher David L